Ageing with HIV: medication use and risk for potential drug-drug interactions
Author(s) -
Catia Marzolini,
D.J. Back,
Rachel Weber,
Hansjakob Furrer,
Matthias Cavassini,
Alexandra Calmy,
Pietro Vernazza,
Enos Bernasconi,
Saye Khoo,
Manuel Battegay,
Luigia Elzi,
Jürg Böni,
Heiner C. Bucher,
Philippe Bürgisser,
Sandro Cattacin,
R Dubs,
Matthias Egger,
Marcus Fischer,
Markus Flepp,
Alessandra Fontana,
P Francioli,
Christoph A. Fux,
Meri Gorgievski,
Huldrych F. Günthard,
Hans H. Hirsch,
Irène Hösli,
Christian R. Kahlert,
Laurent Kaiser,
Urs Karrer,
Christian Kind,
Thomas Klimkait,
Bruno Ledergerber,
G Martinetti,
B. Martı́nez,
N Müller,
David Nadal,
Milos Opravil,
Fred Paccaud,
Giuseppe Pantaleo,
Andri Rauch,
Stephan Regenass,
Martin Rickenbach,
Christoph Rudin,
Patrick Schmid,
D. Schultze,
Jörg Schüpbach,
René Speck,
Patrick Taffé,
Philip Tarr,
Amalio Telenti,
Alexandra Trkola,
Sabine Yerly
Publication year - 2011
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkr248
Subject(s) - drug , human immunodeficiency virus (hiv) , medicine , ageing , pharmacology , intensive care medicine , virology
To compare the use of co-medication, the potential drug-drug interactions (PDDIs) and the effect on antiretroviral therapy (ART) tolerability and efficacy in HIV-infected individuals according to age, ≥ 50 years or <50 years.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom